BANGALEE, A; HANLEY, S; BANGALEE, V. MEDICINE AND THE LAW: Dolutegravir as first-line antiretroviral therapy in South Africa: Beware the one-size-fits-all approach. South African Medical Journal, South Africa, v. 112, n. 10, p. 787–790, 2022. DOI: 10.7196/SAMJ.2022.v112i10.16596. Disponível em: https://samajournals.co.za/index.php/samj/article/view/256. Acesso em: 18 apr. 2026.